EUVIMEDEUVIMED entdecken
Multizentrische StudieEvaluationsstudieOpen Access · CC BY 4.0

Multicenter evaluation of a single-device dengue antibody/antigen rapid test for simultaneous detection of NS1, IgM, and IgG

Zhihai Zhao iD, Mettingal Ramakrishnan Shincy, Lay Sin Teoh, Kadahalli Lingegowda Ravikumar, Haris Ong, Matthew Mak, Yang Du, Mohammad Shafiul Alam iD, Na Xu iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.03669-25 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Zhihai Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, MP Biomedicals Asia Pacific Pte Ltd, Singapore, Singapore. Hauptthemen laut MEDLINE: Dengue, Immunoglobulin G, Immunoglobulin M, Viral Nonstructural Proteins. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MP Biomedicals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue is a major global health burden in tropical and subtropical regions, where timely diagnosis is crucial for clinical management and outbreak control. Although rapid diagnostic tests (RDTs) are widely used at the point of care, their performance varies considerably. This study evaluated the diagnostic accuracy of the ASSURE Dengue Ab/Ag Rapid Test across three independent settings: Singapore, India, and Bangladesh, using reference enzyme-linked immunosorbent assays (ELISAs) and Conformité Européenne (CE)-marked RDTs. In Singapore, 430 characterized serum/plasma samples (141 positive and 289 negative) were tested against Panbio ELISAs and compared with the SD Standard Q Dengue Duo. In India, 300 prospective samples were tested against Panbio ELISAs. In Bangladesh, 85 retrospective samples were evaluated against commercial RDTs, ELISAs, and PCR. In Singapore, ASSURE achieved 100% sensitivity and specificity, outperforming SD Standard Q (sensitivity, 46.81%; specificity, 99.31%). In India, perfect concordance with Panbio ELISAs was observed across non-structural protein 1 (NS1), immunoglobulin M (IgM), and immunoglobulin G (IgG). In Bangladesh, NS1 detection was consistently strong (sensitivity, 100%; specificity, 88.14%–96.00%, depending on the comparator), while antibody detection showed lower sensitivity (IgM, 45.45%; IgG, 42.50%) but high specificity (91.07%–100%). Overall, the ASSURE Dengue Ab/Ag Rapid Test demonstrated superior diagnostic performance compared with CE-marked ELISAs and RDTs, particularly for NS1 antigen detection, and maintained accuracy across multicenter evaluations. These findings support its use as a reliable point-of-care tool for early dengue diagnosis. IMPORTANCE Dengue fever is a mosquito-borne viral infection that affects millions annually. Early diagnosis is critical to reduce complications and improve patient outcomes. While rapid diagnostic tests (RDTs) are widely used, their reliability remains inconsistent. We evaluated the ASSURE Dengue Ab/Ag Rapid Test in Singapore, India, and Bangladesh, comparing it to established laboratory-based enzyme-linked immunosorbent assays and other commercial RDTs. Across studies, the test consistently achieved high accuracy, particularly for non-structural protein 1 antigen detection, which is crucial for identifying acute dengue infection. In contrast, the antibody components (immunoglobulin M and immunoglobulin G) showed variable sensitivity, highlighting the well-documented weaknesses and challenges that dengue tests currently face, particularly in antibody detection. Taken together, these results demonstrate that ASSURE is a dependable point-of-care test, especially for early-phase dengue diagnosis, and can improve patient management and outbreak response in endemic regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueImmunoglobulin GImmunoglobulin MViral Nonstructural ProteinsAntibodies, ViralAntigens, ViralDengue VirusHumansRapid Diagnostic TestsSensitivity and SpecificityBangladeshEnzyme-Linked Immunosorbent AssayIndiaSingaporeRetrospective StudiesProspective Studies

Stichwörter der Autor:innen

ASSURE Dengue Ab/Ag Rapid Testdenguedengue IgG/IgMdengue NS1dengue serologyrapid diagnostic test

Substanzen

Immunoglobulin GImmunoglobulin MViral Nonstructural ProteinsAntibodies, ViralAntigens, Viral

Autor:innen und Institutionen

  • Department of Research and Development, MP Biomedicals Asia Pacific Pte Ltd, Singapore, Singapore.
  • Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bangalore, India.
  • Infectious Diseases Division, International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr, b), Dhaka, Bangladesh.

ORCID-Profile: Zhihai Zhao, Mohammad Shafiul Alam, Na Xu

Förderung

  • MP Biomedicals

Zitieren

APA

Zhao, Z., Shincy, M. R., Teoh, L. S., Ravikumar, K. L., Ong, H., Mak, M., Du, Y., Alam, M. S., & Xu, N. (2026). Multicenter evaluation of a single-device dengue antibody/antigen rapid test for simultaneous detection of NS1, IgM, and IgG. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03669-25

Vancouver

Zhao Z, Shincy MR, Teoh LS, Ravikumar KL, Ong H, Mak M, et al. Multicenter evaluation of a single-device dengue antibody/antigen rapid test for simultaneous detection of NS1, IgM, and IgG. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03669-25

BibTeX
@article{Zhao2026,
  author = {Zhao, Zhihai and Shincy, Mettingal Ramakrishnan and Teoh, Lay Sin and Ravikumar, Kadahalli Lingegowda and Ong, Haris and Mak, Matthew and Du, Yang and Alam, Mohammad Shafiul and Xu, Na},
  title = {Multicenter evaluation of a single-device dengue antibody/antigen rapid test for simultaneous detection of NS1, IgM, and IgG},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.03669-25}
}
Kostenlos starten →